A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

NCT05275426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Ewing-Like Sarcoma

Interventions

DRUG: LY2880070
DRUG: Gemcitabine

Sponsor

Memorial Sloan Kettering Cancer Center